Joint Agreement Signed

On August 19, 2025, the Signing Ceremony for the Cooperative Development and Achievements Commercialization Agreemen tbetween Shanghai Institute of Biomedical and Pharmaceutical Technologies and Aurisco Pharmaceutical Co., Ltd. was held at Shanghai Institute of Biomedical and Pharmaceutical Technologies.

The collaboration includes jointly establishing a synergistic innovation platform, a clinical translation platform, a frontier scientific research system, and an academic exchange platform. Both parties are committed to advancing women’s health drug development, accelerating the translation of scientific achievements from the laboratory to clinical applications, and promoting technological innovation and mutual development.

Attendees at the signing ceremony included Zhao Jian, President of the Shanghai Institute of Biomedical and Pharmaceutical Technologies; Liu Haifeng, Party Committee Secretary; Wang Disong, Vice President; as well as Peng Zhien, Chairman of Aurisco.; Li Jinliang, Board Member.

---